We also found a significant increase in the expression level of AIM2 transcript in the male critical and severe COVID-19 patients compared to the mild (P<0.001 and P=0.04 respectively) and healthy control group (P<0.001 and P=0.02, respectively) (Figure 4C(Fig. 4)). The gene discussed is AIM2; the disease is COVID-19.